Long-term efficacy and safety of prophylactic treatment with recombinant factor IX FC fusion protein (rFIXFc) in subjects with severe or moderate haemophilia B: final longitudinal analysis of B-LONG/kids B-LONG and B-YOND

被引：0
|
作者：
Shapiro, A. D. [1 ]
Kulkarni, R. [2 ]
Ragni, M. V. [3 ]
Mahlangu, J. [4 ,5 ]
Oldenburg, J. [6 ]
Nolan, B. [7 ]
Ozelo, M. C. [8 ]
Willemze, A. [9 ]
Feng, J. [10 ]
Barnowski, C. [10 ]
Barnes, C. [11 ]
机构：
[1] Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA
[2] Michigan State Univ, E Lansing, MI 48824 USA
[3] Univ Pittsburgh, Hemophilia Ctr Western Penn, Pittsburgh, PA USA
[4] Univ Witwatersrand, Haemophilia Comprehens Care Ctr, Fac Hlth Sci, Johannesburg, South Africa
[5] NHLS, Johannesburg, South Africa
[6] Univ Clin Bonn, Inst Expt Haematol & Transfus Med, Bonn, Germany
[7] Our Ladys Childrens Hosp, Dublin, Ireland
[8] Univ Estadual Campinas, Hemoctr UNICAMP, Sao Paulo, Brazil
[9] Sobi, Stockholm, Sweden
[10] Bioverativ, Waltham, MA USA
[11] Royal Childrens Hosp, Melbourne, Vic, Australia
来源：
HAEMOPHILIA | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P009
引用
收藏
页码：39 / 40
页数：2
相关论文
共 50 条
  • [1] Long-term Efficacy of Recombinant Factor IX Fc Fusion Protein (rFIXFc) Prophylaxis in Adults, Adolescents, and Children With Hemophilia B: Longitudinal Analysis of B-LONG, Kids B-LONG, and B-YOND
    Kulkarni, R.
    Ragni, M.
    Mahlangu, J.
    Shapiro, A.
    Oldenburg, J.
    Matsushita, T.
    Nolan, B.
    Feng, J.
    Winding, B.
    Ramirez-Santiago, A.
    Barnowski, C.
    HAEMOPHILIA, 2017, 23 : 23 - 24
  • [2] Long-term safety and efficacy of recombinant factor IX Fc fusion protein (rFIXFc) prophylaxis in children with hemophilia B: Longitudinal analysis of kids B-LONG and B-YOND
    Bennett, Carolyn M.
    Nolan, Beatrice
    Kulkarni, Roshni
    Fischer, Kathelijn
    Perry, David J.
    Barnes, Christopher
    Feng, Jingyuan
    Ferrante, Francesca
    Ramirez-Santiago, Alejandra
    Mei, Baisong
    Barnowski, Chris
    Allen, Geoffrey
    HAEMOPHILIA, 2016, 22 : 47 - 47
  • [3] Long-term safety and efficacy of recombinant factor IX Fc fusion protein (rFIXFc) in adults/adolescents with hemophilia B: Longitudinal analysis of B-LONG and B-YOND
    Mahlangu, Johnny
    Ragni, Margaret V.
    Shapiro, Amy D.
    Pasi, K. John
    Ozelo, Margareth C.
    Oldenburg, Johannes
    Matsushita, Tadashi
    Baker, Ross I.
    Feng, Ingyuan
    Ferrante, Francesca
    Ramirez-Santiago, Alejandra
    Mei, Baisong
    Barnowski, Chris
    HAEMOPHILIA, 2016, 22 : 47 - 47
  • [4] Safety, efficacy and pharmacokinetics of recombinant factor IX FC fusion protein in children with haemophilia B (KIDS B-LONG)
    Fischer, K.
    Kulkarni, R.
    Nolan, B.
    Mahlangu, J.
    Rangarajan, S.
    Gambino, G.
    Diao, L.
    Cristiano, L. M.
    Pierce, G. F.
    Allen, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 87 - 87
  • [5] Long-Term Safety and Efficacy of Recombinant Factor Ix Fc (rFIXFc) for Treatment of Severe Haemophilia B: European Subgroup Interim Analysis of the B-YOND Study
    Chambost, H.
    Perry, D.
    Holmstrom, M.
    Hermans, C.
    Ferrante, F.
    Szamosi, J.
    Lethagen, S.
    HAEMOPHILIA, 2017, 23 : 69 - 70
  • [6] Clinical trial for long-lasting recombinant factor IX-FC (rFIXFc) in subjects with haemophilia B (B-LONG)
    Luk, A.
    Jiang, H.
    Gust, S.
    Defeo-Fraulini, T.
    Roberts, A.
    Pierce, G.
    HAEMOPHILIA, 2011, 17 (02) : 355 - 355
  • [7] Pharmacokinetics Of Recombinant Factor IX Fc Fusion Protein (rFIXFc) In Pediatric Subjects With Hemophilia B: A Interim Analysis Of The Kids B-LONG Study
    Fischer, Kathelijn
    Kulkarni, Roshni
    Bradbury, Myles
    Ragni, Margaret V.
    Rangarajan, Savita
    Dong, Yingwen
    Li, Shuanglian
    Jiang, Haiyan
    Nugent, Karen
    Pierce, Glenn F.
    Allen, Geoffrey
    BLOOD, 2013, 122 (21)
  • [8] Treatment of bleeding episodes in subjects with haemophilia B with the long-lasting recombinant factor IX Fc fusion protein (rFIXFc) in the phase 3 B-LONG study
    Pasi, J.
    Josephson, N.
    Mahlangu, J.
    Perry, D.
    Powell, J.
    Ragni, M.
    Valentino, L. A.
    Krassova, S.
    Nugent, K.
    Brennan, A.
    Innes, A.
    Luk, A.
    Pierce, G. F.
    Allen, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 359 - 359
  • [9] Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study
    Powell, Jerry S.
    Apte, Shashikant
    Chambost, Herve
    Hermans, Cedric
    Jackson, Shannon
    Josephson, Neil C.
    Mahlangu, Johnny N.
    Ozelo, Margareth C.
    Peerlinck, Kathelijne
    Pasi, John
    Perry, David
    Ragni, Margaret V.
    Wang, Xuefeng
    Jiang, Haiyan
    Li, Shuanglian
    Cristiano, Lynda M.
    Innes, Alison
    Nugent, Karen
    Brennan, Aoife
    Luk, Alvin
    Allen, Geoffrey
    Pierce, Glenn F.
    Robinson, Brian
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (01) : 124 - 134
  • [10] Low Bleeding Rates with Increase or Maintenance of Physical Activity in Patients Treated with Recombinant Factor IX FC Fusion Protein (rFIXFc) in the B-LONG and Kids B-LONG Studies
    Windyga, J.
    Kulkarni, R.
    Shapiro, A. D.
    Ragni, M. V.
    Pasi, K. J.
    Ozelo, M. C.
    Tsao, E.
    Allen, G.
    Mei, B.
    HAEMOPHILIA, 2016, 22 : 19 - 20
12345